$23M sweet spot round size
Most of their 18 investments are in rounds between $8.6M and $56M
2005
Cellenkos, Inc. raised $15M on November 4, 2021
Investors: BioVeda China Fund
Oculis S.A. raised $57M on May 4, 2021
Investors: Nan Fung Life Sciences, Tekla Capital Management, VI Partners AG, Earlybird Venture Capital, Wille Finance and BioVeda China Fund
Drug Farm Inc raised $56M on February 9, 2021
Investors: 浙江民营企业联合投资股份有限公司, WuXi AppTec and BioVeda China Fund
Undisclosed raised $104M on January 1, 2021
Investors: 深圳蓝海创业投资基金管理有限公司 and BioVeda China Fund
广东盛泽康华生物医药有限公司 raised undisclosed on September 23, 2020
Investors: BioVeda China Fund
- raised $325M on July 9, 2019
Investors: Athena Capital, Redmile Group, The Invus Group, Jebsen Capital and BioVeda China Fund
Stealth BioTherapeutics raised $100M on June 18, 2018
Investors: Kingdon Capital Management, Sagamore Investment Management and BioVeda China Fund
MicuRx Pharmaceuticals, Inc. raised $15M on December 7, 2017
Investors: 北京德联运通投资管理有限公司 and BioVeda China Fund
Undisclosed raised $50M on December 6, 2017
Investors: Tasly and BioVeda China Fund
祐和医药科技(北京)有限公司 raised $10M on July 1, 2017
Investors: BioVeda China Fund